The Liz Mann Fund increases awareness of women’s cancers and raises money for the Women’s Cancer Research Centre (WCRC), which is conducting research into improved prevention, diagnosis and treatments for gynaecological (ovarian and cervical) and breast cancers.
|
 | A young woman who travelled the world to educate and provide aid and support to struggling communities, Liz Mann left a trail of hope and inspiration in her wake.
Hope and inspiration are the foundations of the Liz Mann Fund at the Women’s.
After her premature death from ovarian cancer, Liz’s family and friends decided to establish a fund in her name and continue in her benevolent footsteps.
Liz’s Fund brings together the high calibre facilities and expertise at the Royal Women’s Hospital with those in the community who feel that fighting women’s cancers is important.
| >> Donate to the Liz Mann Fund now
|
| |
|
|
|
|
liz's fund timeline
|
| The Women’s Cancer Research Centre (WCRC) is established to consolidate investigation into women’s cancers at the Royal Women’s Hospital
|
| | Liz Mann passes away after a battle with ovarian cancer
|
| | The first Liz’s Fund information session highlights Liz Mann’s story, the aims of Liz’s Fund, the symptoms of ovarian cancer and the work undertaken at the WCRC
|
| | Liz's Fund gleans over $119,000 for the WCRC donated by 950 donors world-wide
|
| | Supporters of Liz’s Fund are invited to the Women’s to commemorate the first anniversary of Liz's death and meet the WCRC team
|
| | Fundraising activities supporting Liz’s Fund gross almost $200,000
|
|
|
|
|
|
|
The Women's Cancer Research Centre
|
Over the past couple of years, the team at the WCRC – using donations made to the Liz Mann Fund – have made several important observations about exactly how ovarian cancer cells become resistant to one of the two major components of ovarian cancer chemotherapy. The Women’s research findings are pointing the international research community towards new therapeutic targets that might sensitize resistant cells to chemotherapy and thus give patients with advanced epithelial ovarian cancer a better chance of fighting their disease.
|
>> Donate to the Liz Mann Fund now
|
Read more about cancer research and oncology services at the Women's in Our Stories community newsletter.
|
